DOI: 10.25881/20728255_2022_17_4_2_75


Malofei A.M. 1, 2, Ablitsov A.Yu.2, Orlov S.S.2, Khrupkin V.I.1, Gallуamov E.A.1, Romanikhin A.I.1, Diduev G.I.1, Surkov A.I.1

1 GBUZ City Clinical Hospital No. 23 named. I. V. Davydovsky Department of Health of the City of Moscow, Moscow

2 Pirogov National Medical and Surgical Center, Moscow


In connection with the emergence and increase in the incidence of a new coronavirus infection SARS-CoV-2, there is an increasing amount of data on the characteristics of the pathogen, epidemiology, pathogenesis and morphological changes, features of the clinical course, outcomes, various treatment tactics and developed methods for the prevention of this viral disease, which poses an accentuated danger to people of the older age group. We present our experience in the treatment of complications from the bronchopulmonary system in the stage of late purulent and widespread destructive complications against the background of covid-associated pneumonia.

Keywords: pleural empyema, covid-associated pneumonia, videothoracoscopy, lung gangrene, lung abscess, new coronavirus infection.


1. Zaratyants OV, Malyavin AG, Samsonova MV et al. Pathomorphological changes in the lungs at Covid-19: clinical and therapeutic parallels. Therapy. 2020; 6(5): 35-46. (In Russ.)

2. Telyashov AD, Gallyamov EA, Khrupkin VI et al. Methods of treatment of pleuropulmonary complications of covid-associated pneumonia. Voyenno-meditsinskiy zhurnal. 2021; 350(10): 37-43. (In Russ.)

3. Beaucoté V, Plantefève G, Tirolien JA et al. Lung Abscess in Critically Ill Coronavirus Disease 2019 Patients With Ventilator-Associated Pneumonia: A French Monocenter Retrospective Study. Crit Care Explor. 2021; 3(7): e0482. doi: 10.1097/CCE.0000000000000482.

4. Blonz G, Kouatchet A, Chudeau N et al. Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region. Crit Care. 2021; 25(1): 72. doi: 10.1186/s13054-021-03493-w.

5. Tyurin IE, Strutynskaya AD. Visualization of changes in the lungs during coronavirus infection (literature review and own data). Pulmonology. 2020; 30(5): 658-670. (In Russ.) doi: 10.18093/0869-0189-2020-30-5-658-670.

6. Zabozlaev FG, Kravchenko EV, Gallyamov AR. Pathological anatomy of the lungs in a new coronavirus infection (COVID-19). Preliminary analysis of autopsy studies. Klin Practice. 2020; 11(2): 21-37. (In Russ.) doi: 10.17816/clinpract34849.

7. Kalenchits TI, Kabak SL, Primak SV, Shirinliev NM. Lung abscess as a complication of COVID-19 pneumonia: a clinical case. Tuberculosis and Lung Diseases. 2021; 99(12): 7-13. (In Russ.) doi: 10.21292/2075-1230-2021-99-12-7-12.

8. Gostishchev VK. Infection in thoracic surgery. Guide for doctors. M.: Geotar-Media. 2004: 583. (In Russ.)

9. Ionov PM, Yelkin AV, Deinega IV, Yakovlev GA. Clinic, diagnosis, treatment and outcomes of acute abscesses of lungs in patients with HIV infection. Vestn Khir Im I I Grek. 2020; 179(3): 69-74. (In Russ.) doi: 10.24884/0042-4625-2020-179-3-69-74.

10. Ermashkovich SN, Petukhov VI, Kuntsevich MV. The results of the application of the method of programmed miniotorcotomium using vacuum-acier therapy in acute lung abscesses. In: Mater. 75th scientific session of university employees. Vitebsk, 2020: 9-12. (In Russ.)

11. Timerbulatov MV, Zabelin MV, Timerbulatov ShV et al. Postoperative complications in patients infected with COVID-19 (literature review). Vestn Khir Im I I Grek. 2021; 180(1): 118-122. (In Russ.) doi: 10.24884/0042-4625-2021-180-1-118-122.

12. Sziklavari Z, Ried M, Hofmann HS. Vacuum-assisted closure therapy in the management of lung abscess. J Cardiothorac Surg. 2014; 9: 157. doi: 10.1186/s13019-014-0157-x.

13. Pandey P, Agarwal S, Rajkumar. Lung Pathology in COVID-19: A Systematic Review. Int J Appl Basic Med Res. 2020; 10(4): 226-233. doi: 10.4103/ ijabmr.IJABMR_381_20.

14. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054-1062. doi: 10.1016/S0140-6736 (20)30566-3.

15. Patent RUS № 2766521С1/15.03.2022. Lutsevich OE, Gallyamov EA, Busyrev YuB, Telyashov AD, Diduev GI, Malofei AM, Gadlevsky GS, Erin SA, Gololobov GYu, Gallyamov EE. A method for the treatment of purulent-destructive lung diseases. (In Russ.)

For citation

Malofei A.M. , Ablitsov A.Yu., Orlov S.S., Khrupkin V.I., Gallуamov E.A., Romanikhin A.I., Diduev G.I., Surkov A.I. Features of the treatment of pleuropulmonary complications of covid-associated pneumonia. Bulletin of Pirogov National Medical & Surgical Center. 2022;17(4-2):75-80. (In Russ.)